---
subject: FDA Alert - Drug Safety Communication Gadolinium-based Contrast Agents (GBCAs) Retained in Body New Class Warnings
---

{{> header-secondary }}

<wrapper class="header header-primary">
	<container>
		<row class="collapse">
			<columns small="12" large="6" valign="middle">
				<img class="logo logo-ddc small-float-center" src="https://www.drugs.com/newsletters/src/logo-ddc.jpg" width="211" height="44" alt="Drugs.com">
			</columns>
			<columns small="12" large="6">
				<p class="small-text-center text-right" valign="middle">
					<span class="header-title">FDA Medwatch Alert</span><br>
					<span class="header-sub-title">PLACEHOLDER_DATE</span>
				</p>
			</columns>
		</row>
	</container>
</wrapper>

<container>
	<row>
		<columns small="12">

			<h2><a href="#">Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication - Retained in Body; New Class Warnings</a></h2>
			<spacer size="8"></spacer>
			<p><strong>Audience:</strong> Radiology, Health Care Professional, Patient.</p>

			<p><strong>ISSUE:</strong> FDA is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) concerning gadolinium remaining in patientsâ€™ bodies, including the brain, for months to years after receiving these drugs. Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function, and FDA has concluded that the benefit of all approved GBCAs continues to outweigh any potential risks.</p>

			<center>
				<button href="PLACEHOLDER_LINK" class="radius btn-offset">Read More</button>
			</center>

			<spacer size="16"></spacer>
			<small class="text-muted"><strong>Sent to subscribers of:</strong> gadobenate dimeglumine systemic, gadodiamide systemic, gadopentetate dimeglumine systemic, gadoteridol systemic, gadoversetamide systemic, gadoxetate disodium systemic, gadofosveset trisodium systemic, gadobutrol systemic, gadoterate meglumine systemic, Diagnosis and Investigation</small>

			<spacer size="24"></spacer>
			<hr>
			<center>
				<img class="logo-medwatch" src="https://www.drugs.com/newsletters/src/logo-medwatch.jpg" width="154" height="60" alt="">
			</center>

		</columns>
	</row>
</container>

{{> footer-social }}